Stockscreener 앱 받기
1.35
0.73%
-0.02
전일 마감가:
$1.37
열려 있는:
$1.38
하루 거래량:
75,292
Relative Volume:
0.15
시가총액:
$61.03M
수익:
$19.94M
순이익/손실:
$-37.37M
주가수익비율:
-1.2981
EPS:
-1.04
순현금흐름:
$-33.38M
1주 성능:
-3.55%
1개월 성능:
+13.81%
6개월 성능:
-1.45%
1년 성능:
-50.36%
1일 변동 폭
$1.32
$1.39
1주일 범위
$1.25
$1.485
52주 변동 폭
$0.595
$4.18
웨어울프 테라 Stock (HOWL) Company Profile
명칭
Werewolf Therapeutics Inc
전화
617-952-0555
주소
200 TALCOTT AVENUE, WATERTOWN
HOWL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.36 | 62.37M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.90 | 122.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.07 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.36 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.02 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
292.26 | 31.91B | 3.81B | -644.79M | -669.77M | -6.24 |
웨어울프 테라 Stock (HOWL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-03 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-24 | 개시 | Wedbush | Outperform |
| 2023-06-06 | 재개 | Jefferies | Buy |
| 2021-09-10 | 개시 | BofA Securities | Buy |
| 2021-05-25 | 개시 | Evercore ISI | Outperform |
| 2021-05-25 | 개시 | H.C. Wainwright | Buy |
| 2021-05-25 | 개시 | Jefferies | Buy |
| 2021-05-25 | 개시 | SVB Leerink | Outperform |
모두보기
웨어울프 테라 주식(HOWL)의 최신 뉴스
What analysts say about Werewolf Therapeutics Inc. stockHigh-octane gains - PrintWeekIndia
Is Werewolf Therapeutics Inc. stock a growth or value playHigh-octane financial growth - jammulinksnews.com
Why Werewolf Therapeutics Inc. stock is on top investor watchlistsHigh-profit capital plays - jammulinksnews.com
Is Werewolf Therapeutics Inc. stock overhyped or has real potentialMarket-leading growth rates - jammulinksnews.com
What drives Werewolf Therapeutics Inc. stock priceSky-high return potential - Autocar Professional
Is Werewolf Therapeutics Inc. a good long term investmentRapidly growing investment returns - Autocar Professional
Werewolf Therapeutics Inc. Stock Analysis and ForecastSuperior stock selection - jammulinksnews.com
How Werewolf Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser
Why Werewolf Therapeutics Inc. stock attracts strong analyst attentionHigh Potential Shares - Newser
What makes Werewolf Therapeutics Inc. stock price move sharplyInvestor Favorite Picks - Newser
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know - MSN
Vontobel Holding Ltd. Acquires New Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics to Present Innovative IL-2 INDUKINE Development at KidneyCAN 7th Annual Kidney Cancer Research Summit - Nasdaq
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit - GlobeNewswire
Werewolf Therapeutics: A High-Risk, High-Potential Bet in Cancer Immunotherapy - criticalcontrolroomworld.com
Werewolf Therapeutics (NASDAQ:HOWL) Trading Up 1% – What’s Next? - Defense World
Werewolf Therapeutics Adopts New Bylaws and Elects Directors - TipRanks
Two Sigma Investments LP Sells 87,168 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics to Participate in the BIO International Convention - GlobeNewswire
Jane Street Group LLC Acquires 39,564 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Two Sigma Advisers LP Sells 117,200 Shares of Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shares Sold by Millennium Management LLC - Defense World
웨어울프 테라 (HOWL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
웨어울프 테라 주식 (HOWL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 14 '25 |
Buy |
0.98 |
162,539 |
159,288 |
6,237,482 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
May 13 '25 |
Buy |
0.98 |
52,974 |
51,915 |
6,074,943 |
| MPM BioVentures 2014, L.P. | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
1,963 |
2,061 |
3,208,793 |
| EVNIN LUKE | Director |
Mar 27 '25 |
Sale |
1.05 |
2,425 |
2,546 |
4,309,860 |
| GADICKE ANSBERT | 10% Owner |
Mar 27 '25 |
Sale |
1.05 |
4,386 |
4,605 |
6,718,670 |
1.74%
0.00%
자본화:
|
볼륨(24시간):